High-Dose Aspirin Is Required to Influence Plasma Fibrin Network Structure in Patients With Type 1 Diabetes

OBJECTIVE: Patients with type 1 diabetes form a less permeable fibrin network, which could contribute to their increased risk of cardiovascular disease (CVD). Low-dose aspirin treatment is the standard in the management of CVD; however, the effect seems reduced in patients with diabetes. We investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Tehrani, Sara, Antovic, Aleksandra, Mobarrez, Fariborz, Mageed, Koteiba, Lins, Per-Eric, Adamson, Ulf, Wallén, Håkan N., Jörneskog, Gun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263903/
https://www.ncbi.nlm.nih.gov/pubmed/22148098
http://dx.doi.org/10.2337/dc11-1302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263903/
https://www.ncbi.nlm.nih.gov/pubmed/22148098
http://dx.doi.org/10.2337/dc11-1302

Ejemplares similares